ethylcholine aziridinium has been researched along with 5,7-dihydroxytryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, P; Janowsky, A; Long, R; Paul, SM; Schweri, MM; Skolnick, P | 1 |
| Arnswald, A; Fink, H; Hellweg, R; Hörtnagl, H; Kay, S; Morgenstern, R; Thomas, H; von Richthofen, S | 1 |
2 other study(ies) available for ethylcholine aziridinium and 5,7-dihydroxytryptamine
| Article | Year |
|---|---|
The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.
Topics: 5,7-Dihydroxytryptamine; Animals; Aziridines; Choline; Corpus Striatum; Dopamine; Hydroxydopamines; Kinetics; Male; Methylphenidate; Oxidopamine; Rats; Rats, Inbred Strains; Reserpine; Stereotaxic Techniques; Synaptosomes | 1985 |
Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Animals; Aziridines; Biomarkers; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Drug Resistance; Hippocampus; Male; Nerve Growth Factors; Nerve Tissue Proteins; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Septum Pellucidum; Serotonin; Serotonin Agents | 2001 |